Antonio Craxì Selected Research

oxidized low density lipoprotein

1/2021

PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Craxì Research Topics

Disease

63	Fibrosis (Cirrhosis) 07/2022 - 07/2002
41	Chronic Hepatitis C 01/2022 - 06/2002
29	Infections 01/2022 - 06/2002
27	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2002
25	Liver Diseases (Liver Disease) 01/2022 - 07/2002
24	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 04/2003
20	Non-alcoholic Fatty Liver Disease 07/2022 - 05/2011
9	Chronic Hepatitis B 01/2019 - 01/2003
7	Chronic Hepatitis (Chronic Active Hepatitis) 02/2014 - 07/2002
6	Hepatitis 01/2022 - 10/2010
6	Fatty Liver 11/2021 - 10/2012
6	Hypertension (High Blood Pressure) 01/2020 - 10/2012
6	Insulin Resistance 11/2015 - 07/2008
6	Neoplasms (Cancer) 09/2015 - 04/2005
5	Inflammation (Inflammations) 01/2015 - 12/2010
4	Disease Progression 01/2021 - 01/2005
4	Iron Overload 10/2010 - 07/2004
3	Type 2 Diabetes Mellitus (MODY) 12/2020 - 01/2013
3	Hepatitis C 01/2018 - 09/2002
3	Crohn Disease (Crohn's Disease) 11/2016 - 12/2010
3	Autoimmune Hepatitis 01/2015 - 08/2010
3	Ascites 12/2013 - 09/2008
3	Liver Neoplasms (Liver Cancer) 03/2013 - 04/2005
3	Portal Hypertension 01/2012 - 10/2007
2	COVID-19 01/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 12/2020 - 10/2010
2	Obesity 01/2019 - 11/2018
2	Hyperferritinemia 01/2019 - 05/2009
2	Necrosis 12/2014 - 01/2013
2	Thalassemia 05/2012 - 10/2010
2	Persistent Infection 05/2012 - 10/2006
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 08/2010 - 01/2003
2	Sclerosing Cholangitis 08/2010 - 01/2003
2	Body Weight (Weight, Body) 11/2006 - 09/2004
1	HIV Infections (HIV Infection) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2021

Drug/Important Bio-Agent (IBA)

45	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2002
26	Ribavirin (Virazole)FDA LinkGeneric 10/2018 - 09/2002
23	InterferonsIBA 12/2017 - 09/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
8	Hepatitis B e AntigensIBA 01/2019 - 07/2002
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 06/2002
7	Biomarkers (Surrogate Marker)IBA 12/2020 - 07/2002
7	IronIBA 01/2019 - 07/2004
7	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 10/2014 - 01/2012
6	Alanine Transaminase (SGPT)IBA 07/2022 - 04/2009
6	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2002
6	telaprevirIBA 05/2014 - 01/2012
5	AlbuminsIBA 01/2022 - 09/2012
5	Pharmaceutical PreparationsIBA 01/2019 - 04/2011
5	Triglycerides (Triacylglycerol)IBA 01/2017 - 11/2010
5	Interferon-alpha (Interferon Alfa)IBA 11/2015 - 09/2002
5	Lamivudine (Epivir)FDA Link 01/2009 - 07/2002
4	CholesterolIBA 11/2021 - 05/2008
4	Ferritins (Ferritin)IBA 01/2019 - 05/2008
4	Sorafenib (BAY 43-9006)FDA Link 09/2015 - 03/2009
3	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 02/2004
3	HDL CholesterolIBA 11/2018 - 11/2010
3	SofosbuvirIBA 01/2018 - 05/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2014
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 01/2012
3	Interferon alpha-2 (Roferon-A)FDA Link 09/2005 - 02/2004
2	glecaprevir and pibrentasvirIBA 06/2021 - 05/2021
2	VaccinesIBA 01/2021 - 05/2014
2	SodiumIBA 01/2020 - 12/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2018
2	daclatasvirIBA 01/2019 - 01/2018
2	Ritonavir (Norvir)FDA Link 10/2018 - 01/2017
2	dasabuvirIBA 10/2018 - 01/2017
2	ombitasvirIBA 10/2018 - 01/2017
2	paritaprevirIBA 10/2018 - 01/2017
2	Transaminases (Aminotransferases)IBA 03/2016 - 12/2014
2	Vitamin D FDA LinkGeneric 01/2015 - 01/2012
2	FructoseIBA 03/2014 - 12/2013
2	LipidsIBA 01/2014 - 03/2012
2	BilirubinIBA 12/2013 - 09/2012
2	CreatinineIBA 12/2013 - 01/2013
2	LDL CholesterolIBA 10/2012 - 03/2012
2	TransferasesIBA 01/2012 - 08/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2010 - 01/2009
2	Interleukin-10 (Interleukin 10)IBA 12/2010 - 07/2003
2	CytokinesIBA 12/2010 - 07/2003
2	EnzymesIBA 08/2009 - 04/2003
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	elbasvirIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	atezolizumabIBA 01/2022
1	grazoprevirIBA 01/2022
1	fibroblast growth factor 21IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021

Therapy/Procedure

47	Therapeutics 01/2022 - 07/2002
8	Liver Transplantation 01/2022 - 10/2004
2	Transplantation 05/2014 - 07/2002
2	Radiofrequency Ablation 01/2013 - 10/2009
2	Drug Therapy (Chemotherapy) 01/2012 - 07/2010
2	Chelation Therapy (Therapy, Chelation) 10/2010 - 08/2008
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Tattooing 01/2021